Therapeutic Effects of Coumarins with Different Substitution Patterns
The use of derivatives of natural and synthetic origin has gained attention because of their therapeutic effects against human diseases. Coumarins are one of the most common organic molecules and are used in medicine for their pharmacological and biological effects, such as anti-inflammatory, anticoagulant, antihypertensive, anticonvulsant, antioxidant, antimicrobial, and neuroprotective, among others. In addition, coumarin derivates can modulate signaling pathways that impact several cell processes. The objective of this review is to provide a narrative overview of the use of coumarin-derived compounds as potential therapeutic agents, as it has been shown that substituents on the basic core of coumarin have therapeutic effects against several human diseases and types of cancer, including breast, lung, colorectal, liver, and kidney cancer. In published studies, molecular docking has represented a powerful tool to evaluate and explain how these compounds selectively bind to proteins involved in various cellular processes, leading to specific interactions with a beneficial impact on human health. We also included studies that evaluated molecular interactions to identify potential biological targets with beneficial effects against human diseases.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
Journal of Molecular Structure
6 publications, 4.55%
|
|
|
Molecules
6 publications, 4.55%
|
|
|
ChemistrySelect
5 publications, 3.79%
|
|
|
Russian Journal of Bioorganic Chemistry
5 publications, 3.79%
|
|
|
International Journal of Molecular Sciences
4 publications, 3.03%
|
|
|
RSC Advances
4 publications, 3.03%
|
|
|
Results in Chemistry
4 publications, 3.03%
|
|
|
Archiv der Pharmazie
3 publications, 2.27%
|
|
|
European Journal of Medicinal Chemistry Reports
3 publications, 2.27%
|
|
|
Scientific Reports
3 publications, 2.27%
|
|
|
3 Biotech
3 publications, 2.27%
|
|
|
MolBank
2 publications, 1.52%
|
|
|
Crystals
2 publications, 1.52%
|
|
|
Antibiotics
2 publications, 1.52%
|
|
|
Chemical Papers
2 publications, 1.52%
|
|
|
Chemistry and Biodiversity
2 publications, 1.52%
|
|
|
Processes
2 publications, 1.52%
|
|
|
Journal of Heterocyclic Chemistry
2 publications, 1.52%
|
|
|
Organics
1 publication, 0.76%
|
|
|
Journal of Medicinal Chemistry
1 publication, 0.76%
|
|
|
Medicine (United States)
1 publication, 0.76%
|
|
|
Journal of Herbal Medicine
1 publication, 0.76%
|
|
|
Plants
1 publication, 0.76%
|
|
|
Pharmaceuticals
1 publication, 0.76%
|
|
|
South African Journal of Botany
1 publication, 0.76%
|
|
|
Symmetry
1 publication, 0.76%
|
|
|
Current Issues in Molecular Biology
1 publication, 0.76%
|
|
|
Journal of Parasitic Diseases
1 publication, 0.76%
|
|
|
Technology and Health Care
1 publication, 0.76%
|
|
|
1
2
3
4
5
6
|
Publishers
|
5
10
15
20
25
30
35
40
|
|
|
Elsevier
38 publications, 28.79%
|
|
|
MDPI
27 publications, 20.45%
|
|
|
Springer Nature
16 publications, 12.12%
|
|
|
Wiley
13 publications, 9.85%
|
|
|
Royal Society of Chemistry (RSC)
8 publications, 6.06%
|
|
|
American Chemical Society (ACS)
5 publications, 3.79%
|
|
|
Taylor & Francis
5 publications, 3.79%
|
|
|
Pleiades Publishing
5 publications, 3.79%
|
|
|
Frontiers Media S.A.
3 publications, 2.27%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.52%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 1.52%
|
|
|
SAGE
1 publication, 0.76%
|
|
|
Walter de Gruyter
1 publication, 0.76%
|
|
|
Spandidos Publications
1 publication, 0.76%
|
|
|
Georg Thieme Verlag KG
1 publication, 0.76%
|
|
|
American Society for Microbiology
1 publication, 0.76%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 0.76%
|
|
|
International Union of Crystallography (IUCr)
1 publication, 0.76%
|
|
|
Hindawi Limited
1 publication, 0.76%
|
|
|
5
10
15
20
25
30
35
40
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.